Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom's Macroglobulinemia”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT00004889
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492050
What this trial is testing

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT02381080
What this trial is testing

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLC 26
Not applicableEnded earlyNCT05645744
What this trial is testing

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseSmall Lymphocytic Lymphoma, Relapsed+8 more
Mustang Bio 3
Testing effectiveness (Phase 2)Study completedNCT00142116
What this trial is testing

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's MacroglobulinemiaLymphoplasmacytic Lymphoma
Steven P. Treon, MD, PhD 25
Testing effectiveness (Phase 2)Ended earlyNCT00060346
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT01647971
What this trial is testing

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins LymphomaB-cell LymphomaWaldenstrom's Macroglobulinemia+4 more
TG Therapeutics, Inc. 39
Testing effectiveness (Phase 2)UnknownNCT00041379
What this trial is testing

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
LifeTime Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02400437
What this trial is testing

Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00045695
What this trial is testing

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 27
Testing effectiveness (Phase 2)Study completedNCT04440059
What this trial is testing

ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia Refractory
Beijing InnoCare Pharma Tech Co., Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT01614821
What this trial is testing

Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 63
Testing effectiveness (Phase 2)Study completedNCT00718419
What this trial is testing

Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma

Who this might be right for
Waldenstrom's MacroglobulinemiaMultiple Myeloma
Eli Lilly and Company 56
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)Study completedNCT02363439
What this trial is testing

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00083707
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 40
Testing effectiveness (Phase 2)Study completedNCT00250926
What this trial is testing

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT02566265
What this trial is testing

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

Who this might be right for
InfluenzaMultiple MyelomaWaldenstrom's Macroglobulinemia+2 more
Yale University 122
Testing effectiveness (Phase 2)UnknownNCT02981745
What this trial is testing

Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaWaldenstrom's Macroglobulinemia+3 more
Centaurus Biopharma Co., Ltd. 200
Load More Results